Following a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), the European Commission on Monday 19th December formally approved Atara Biotherapeutics ...
Story March 4 - Atara Biotherapeutics: While the biotech navigates the fallout from the FDA’s move to halt trials of its allogeneic T-cell immunotherapy Ebvallo and a CAR-T candidate ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Hold rating on Atara Biotherapeutics (ATRA – Research Report) yesterday and set a price ...
Zacks Investment Research on MSN3d
Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the UpgradeAtara Biotherapeutics (ATRA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
After hours: March 14 at 4:05:07 PM EDT Loading Chart for ATRA ...
With cutting-edge technology, a robust regulatory framework, and a highly skilled team, BTCF is committed to driving innovation in cell therapy research and clinical translation, helping to bring next ...
NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bill Enright, CEO and Gemma Brown, CFO of Barinthus Biotherapeutics plc, will be presenting at this year's Investor Summit Virtual on March 11th.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
After hours: March 14 at 7:49:12 p.m. EDT Loading Chart for IOVA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback